Chester County News and Community Website
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA) announced that the U.S. Food and Drug Administration (FDA) this week issued a Complete Response Letter (CRL) regarding its New …
Verrica Receives Complete Response Letter from the FDA Read More
MALVERN, PA — 20n Bio, an AI-powered drug discovery startup focusing on designing new proteins for therapeutics, announced the appointment of LIANG Shide, PhD, as Vice President of Computational Biology, …
Chester County Start-Up Names LIANG Shide PhD, as Vice President of Computational Biology Read More
BERWYN, PA — Inc. magazine recently revealed that AscellaHealth, a global specialty pharmacy and healthcare solutions company, is No. 54 on its third annual Inc. 5000 Regionals: Northeast list, the most …
AscellaHealth Ranks No. 54 on Inc. Magazine’s List of the Northeast’s Fastest-Growing Private Companies Read More
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX) recently announced the initiation of a clinical study evaluating the safety and pharmacokinetics (PK) of ANJESO (meloxicam) injection in pediatric patients (ages …
Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO in Pediatric Patients Following Surgery Read More
BERWYN, PA — Panavance Therapeutics Inc. is a new clinical-stage pharmaceutical company created to advance and develop GP-2250, a patented, novel therapeutic for the treatment of cancer and other therapeutic …
Panavance Therapeutics Inc. Created to Transform Cancer Treatment Read More
BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below.
Virpax Pharmaceuticals Recaps Milestones and Highlights Product Portfolio Read More BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) announced it recently signed a clinical trial agreement with Altasciences Company, Inc. for a First in Human study investigating Epoladerm™ for pain …
Virpax Announces Clinical Trial Site in Canada for First in Human Study of Epoladerm Read More BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) recently reported positive results following the completion of a toxicology and pharmacokinetic study designed to support clinical trials with Epoladerm™, one of …
Virpax Reports Successful Results of Toxicology and Pharmacokinetic Study for Epoladerm Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that this week it has resubmitted the New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum) …
Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that this week the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding its New Drug …
Verrica Pharmaceuticals Receives Complete Response Letter from the FDA Read More